Sleep Testing Services was Vivos Therapeutics’s largest product and service line in fiscal 2025, bringing in $6.04M of $17.44M (35%).
| Product and Service | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|
| Service | $7.64M | — | — | — | |||
| Appliance Sales To Vip | — | — | — | — | |||
| Appliances | — | $6.08M | $5.60M | $3.28M | |||
| Vip | $4.84M | $3.92M | $2.49M | $491.00K | |||
| Appliance Sales To Integrated Providers | — | — | — | — | |||
| Tooth Positioners | — | — | $2.27M | $3.21M | |||
| Sleep Testing Services | $594.00K | $1.19M | $1.28M | $6.04M | |||
| Treatment Centers | — | — | — | $2.18M | |||
| Billing Intelligence Services | $1.17M | $887.00K | $840.00K | $686.00K | |||
| Center Revenue | — | — | — | — | |||
| Myofunctional Therapy Services | $927.00K | $861.00K | $609.00K | $337.00K | |||
| Sponsorship Seminar Other | $114.00K | $676.00K | $1.94M | $1.22M | |||
| Sponsorship/Seminar/Other | — | — | — | — | |||
| Management Service Revenue | — | — | — | — | |||
| Guides | — | $189.00K | — | — | |||
| Bis | $100.00K | — | — | — | |||
| Total | $15.39M | $13.80M | $15.03M | $17.44M |
Vivos Therapeutics brought in $17.44M from its eight product and service lines in fiscal 2025, the year ended December 31, 2025. Vivos Therapeutics regrouped these lines after fiscal 2024, so the total does not compare directly with that year's $15.03M. Sleep Testing Services was the largest at $6.04M (34.6%), ahead of Appliances at $3.28M (18.8%) and Tooth Positioners at $3.21M (18.4%). The other five lines brought in $4.92M combined.
Compared with fiscal 2024, Sleep Testing Services grew fastest, up 371.2% to $6.04M, while Vip fell the most, down 80.2% to $491.00K.
Vivos Therapeutics began breaking out Appliances in fiscal 2023, Tooth Positioners in fiscal 2024 and Treatment Centers in fiscal 2025. Vivos Therapeutics stopped reporting Service ($7.64M in fiscal 2022), Guides ($189.00K in fiscal 2023) and Bis ($100.00K in fiscal 2022) as separate lines.
Vivos Therapeutics (VVOS) reports its revenue by product and service. In fiscal 2025, Sleep Testing Services was its largest product and service line, bringing in $6.04M (34.6% of the total), followed by Appliances at $3.28M (18.8%).
Sleep Testing Services was Vivos Therapeutics' largest product and service line in fiscal 2025, bringing in $6.04M, or 34.6% of the $17.44M total across its eight product and service lines.
Every figure comes from Vivos Therapeutics' annual financial filings, as reported. Each line keeps the name Vivos Therapeutics gives it, and years follow its fiscal calendar.
Vivos Therapeutics' revenue by product and service goes back to fiscal 2019, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.